BAY-299
$295.00
CAS No.: 2080306-23-4
Catalog No.: 184929
Purity: 95%
MF: C25H23N3O4
MW: 429.476
Storage: 2-8 degree Celsius
SMILES: CN1C(=O)N(C)C2=C1C=C(C)C(=C2)N1C(=O)C2=CC=CC3=C2C(=CC=C3CCCO)C1=O
Catalog No.: 184929
Purity: 95%
MF: C25H23N3O4
MW: 429.476
Storage: 2-8 degree Celsius
SMILES: CN1C(=O)N(C)C2=C1C=C(C)C(=C2)N1C(=O)C2=CC=CC3=C2C(=CC=C3CCCO)C1=O
BAY-299; 6-(3-hydroxypropyl)-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione; CAS No.: 2080306-23-4; 6-(3-hydroxypropyl)-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione is classified as a building block for drug discovery within ChemShuttle's product offerings, offering a complex framework for developing novel therapeutics targeting various disease areas. As a chemical synthesis company with expertise in cycle compounds, ChemShuttle provides this compound with detailed information on its synthetic applications and recommended protection strategies for sensitive hydroxy and carboxylic acid groups during multi-step syntheses. The trimethyl substitution enhances the compound's metabolic stability, making it suitable for oral administration in preclinical models. ChemShuttle's custom chemical synthesis services can incorporate additional substituents or modify the existing groups to better match specific research requirements. Researchers benefit from the company's efficient ordering system, which streamlines the procurement process for this and related compounds used in medicinal chemistry projects targeting challenging biological targets.
Reviews
Write Your Own Review